Aarti Pharmalabs Ltd share price logo

Aarti Pharmalabs Ltd Share Price

(AARTIPHARM)

₹733.2▲0.95%

as on 04:01PM, 28 Feb 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Aarti Pharmalabs Ltd Performance

  • Day's Low

    Day's High

    ₹715.9
    Day's Price Range
    ₹751

  • 52 Week's Low

    52 Week's High

    ₹399.55
    52-Week Price Range
    ₹837.25
1 Month Return+ 24.64 %
3 Month Return+ 12.4 %
1 Year Return+ 48.59 %
Previous Close₹740.25
Open₹740.00
Volume6.28L
Upper Circuit-
Lower Circuit-
Market Cap₹6,644.70Cr

Aarti Pharmalabs Ltd Key Statistics

P/E Ratio

26.65

PEG Ratio

4.41

Market Cap

₹6,644.70 Cr

P/B Ratio

2.43

EPS

23.93

Dividend Yield

0.69

Sector

Pharmaceuticals

ROE

13.11

Key events for Aarti Pharmalabs Ltd

  • Aarti Pharmalabs Stock Performance Overview - 20 Feb, 2025

    Aarti Pharmalabs shares closed at Rs. 1,919.60, down 0.68%. The stock has risen 24% over six months, outperforming the Nifty Index, which fell 7.23%.

  • Aarti Pharmalabs Reports Strong Q3 FY25 Results - 19 Feb, 2025

    In Q3 FY25, Aarti Pharmalabs achieved sales of Rs 538 crores, a 20% year-over-year increase, with net profits rising 40% to Rs 74 crores. The stock reached a 52-week high of Rs 832.20 and has gained over 37% in the past six months.

  • Aarti Pharmalabs Declares Interim Dividend for 2024-25 - 14 Feb, 2025

    Aarti Pharmalabs has announced an interim dividend of ₹2.5 per equity share, representing 50% for the financial year 2024-25, reflecting positive shareholder returns.

  • Aarti Pharmalabs Shows Potential for Breakout - 11 Feb, 2025

    Aarti Pharmalabs stock has shown stability with strong Q3 results despite market volatility. Analysts suggest buying above ₹742, targeting ₹825, as momentum builds.

  • Aarti Pharmalabs Reports Strong Q3 Growth and Dividend - 06 Feb, 2025

    Aarti Pharmalabs experienced significant growth in Q3 FY25, with a 40% increase in net profit and a declared interim dividend. The stock surged following these positive results, reflecting strong operational performance and improved margins.

Insights on Aarti Pharmalabs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, AARTIPHARM stock has moved up by 24.6%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 35.16% to 36.33% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 54.62 Cr → 73.99 Cr (in ₹), with an average increase of 26.2% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 7.38% to 8.64% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 462.51 Cr → 542.81 Cr (in ₹), with an average increase of 14.8% per quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 46.10% to 44.66% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 4.93% to 3.93% in Dec 2024 quarter

Aarti Pharmalabs Ltd Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹448.69Cr (-)₹505.77Cr (↑12.72%)₹555.49Cr (↑9.83%)₹458.03Cr (↓17.54%)₹537.78Cr (↑17.41%)
Net Income₹52.76Cr (-)₹65.25Cr (↑23.67%)₹55.45Cr (↓15.02%)₹54.62Cr (↓1.50%)₹73.99Cr (↑35.46%)
Net Profit Margin11.76% (-)12.90% (↑9.69%)9.98% (↓22.64%)11.92% (↑19.44%)13.76% (↑15.44%)
Value in ₹ crore
Details2021202220232024
Total Assets₹0.25Cr (-)₹1,826.83Cr (↑7,30,632.00%)₹1,978.32Cr (↑8.29%)₹2,299.22Cr (↑16.22%)
Total Liabilities₹0.02Cr (-)₹542.56Cr (↑27,12,700.00%)₹539.74Cr (↓0.52%)₹677.76Cr (↑25.57%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow-₹0.02Cr (-)- (↓100.00%)-₹64.84Cr (-)₹215.88Cr (↓432.94%)₹183.69Cr (↓14.91%)

Index Inclusions

BSE Healthcare

₹38,211.72

-2.19 (▲-854.91%)

BSE Small-Cap

₹43,082.90

-2.33 (▲-1028.74%)

S&P BSE AllCap

₹10,471.31

0.68 (▲71.07%)

Aarti Pharmalabs Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
44.66%
-3.14
Foreign Institutions
8.64%
17.15
Mutual Funds
3.93%
-20.19
Retail Investors
36.33%
3.33
Others
6.44%
0.07

Aarti Pharmalabs Ltd Key Indicators

Details20232024
Earning Per Share (₹)21.3523.93
Details202220232024
Return On Equity %16.6212.6113.11
Details202220232024
Return On Assets %6.699.789.43
Details20232024
Book Value Per Share (₹)171.97193.88

Aarti Pharmalabs Ltd Valuation

Aarti Pharmalabs Ltd in the last 5 years

  • Overview

  • Trends

Lowest (11.23x)

February 2, 2023

Today (26.65x)

February 28, 2025

Industry (50.30x)

February 28, 2025

Highest (29.40x)

February 18, 2025

LowHigh

Aarti Pharmalabs Ltd Earnings and Dividends

  • Aarti Pharmalabs Ltd Earnings Results

    Aarti Pharmalabs Ltd’s net profit jumped 40.24% since last year same period to ₹73.99Cr in the Q3 2024-2025. On a quarterly growth basis, Aarti Pharmalabs Ltd has generated 35.46% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Aarti Pharmalabs Ltd Dividends February,2025

    In the quarter ending December 2024, Aarti Pharmalabs Ltd has declared dividend of ₹2.50 - translating a dividend yield of 0.75%.

    Read More about Dividends

Aarti Pharmalabs Ltd Technicals Summary

Bearish

Neutral

Bullish

Bullish

Aarti Pharmalabs Ltd is currently in a Bullish trading position according to technical analysis indicators.

More on Technical Analysis

Aarti Pharmalabs Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Aarti Pharmalabs Ltd
Aarti Pharmalabs Ltd
NA₹6,644.70 Cr30.87%0.57₹216 Cr₹1,852 Cr
Sanofi India Ltd
Sanofi India Ltd
BUY₹11,541.60 Cr-6.3%0.52₹602 Cr₹2,851 Cr
Denis Chem Lab Ltd
Denis Chem Lab Ltd
NA₹150.63 Cr55.12%0.51NANA
Chandra Bhagat Pharma Ltd
Chandra Bhagat Pharma Ltd
NA₹49.04 Cr9.71%0.68NANA
Syschem (India) Ltd
Syschem (India) Ltd
NA₹171.17 Cr81.39%0.58NANA
See all

About Aarti Pharmalabs Ltd

Aarti Pharmachem Limited was incorporated as a Public Limited Company in 2019. The Company is engaged in manufacturer of Active Pharmaceutical Ingredients API Pharmaceutical Intermediates New Chemical Entities NCE and Xanthine Derivatives situated in India.In 2001 the Company commissioned first API manufacturing Unit in Dombivali Unit 1 and started Xanthine Unit further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005 commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes MT per month in 2016. It expanded block for CSD Vapi and API Tarapur units in 2022.The Scheme of Arrangement for the demerger of Pharma Business Undertaking from Aarti Industries Limited into its wholly owned subsidiary Aarti Pharmalabs Limited was effective on October 17 2022 and operational from July 1 2021. Pursuant to the said Demerger Scheme Aarti Industries Limited hived off its Pharmaceutical Division into a separate entity Aarti Pharmalabs Limited and accordingly all the assets and liabilities pertaining to the Pharma Business Undertaking got transferred and vested into the Company effective from the above said Date.Thereafter the Company in 2023 commercialised Block V at Tarapur Unit 4. Again it enhanced Xanthine capacity to 5000 TPA in 2023.90626008 Equity Shares of Rs 5/ each got listed effective January 30 2023..

Share Price: ₹733.20 per share as on 28 Feb, 2025 04:01 PM
Market Capitalisation: ₹6,644.70Cr as of today
Revenue: ₹537.78Cr as on December 2024 (Q4 24)
Net Profit: ₹73.99Cr as on December 2024 (Q4 24)
Listing date: 30 Jan, 2023
Chairperson Name: Rashesh C Gogri
OrganisationAarti Pharmalabs Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Aarti Pharmalabs Ltd

What is Aarti Pharmalabs Ltd price today?

Aarti Pharmalabs Ltd share price today stands at ₹733.2, Open: ₹740, Previous Close: ₹740.25, High: ₹751, Low: ₹715.9, 52 Week High: ₹837.25, 52 Week Low: ₹399.55.

How to Buy Aarti Pharmalabs Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Aarti Pharmalabs Ltd shares

Is Aarti Pharmalabs Ltd listed on NSE?

Aarti Pharmalabs Ltd is listed on NSE

Is Aarti Pharmalabs Ltd listed on BSE?

Aarti Pharmalabs Ltd is listed on BSE

What are today's High and Low prices of Aarti Pharmalabs Ltd?

  • Today's highest price of Aarti Pharmalabs Ltd is ₹751.
  • Today's lowest price of Aarti Pharmalabs Ltd is ₹715.9.

What are today's traded volumes of Aarti Pharmalabs Ltd?

Today's traded volume of Aarti Pharmalabs Ltd(AARTIPHARM) is 6.28L.

What is today's market capitalisation of Aarti Pharmalabs Ltd?

Today's market capitalisation of Aarti Pharmalabs Ltd(AARTIPHARM) is ₹6644.7Cr.

What is the 52 Week High and Low Range of Aarti Pharmalabs Ltd?

Aarti Pharmalabs Ltd (AARTIPHARM)
Price
52 Week High
₹837.25
52 Week Low
₹399.55

How much percentage Aarti Pharmalabs Ltd is down from its 52 Week High?

Aarti Pharmalabs Ltd (AARTIPHARM) share price is ₹733.2. It is down -12.43% from its 52 Week High price of ₹837.25

How much percentage Aarti Pharmalabs Ltd is up from its 52 Week low?

Aarti Pharmalabs Ltd (AARTIPHARM) share price is ₹733.2. It is up 83.51% from its 52 Week Low price of ₹399.55

What are the historical returns of Aarti Pharmalabs Ltd?

Aarti Pharmalabs Ltd (AARTIPHARM)
Returns
1 Day Returns
-7.05%
1 Month Returns
24.64%
3 Month Returns
12.4%
1 Year Returns
48.59%

What is the PE ratio of Aarti Pharmalabs Ltd today?

PE Ratio of Aarti Pharmalabs Ltd is 26.65

PE ratio = Aarti Pharmalabs Ltd Market price per share / Aarti Pharmalabs Ltd Earnings per share